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A-kinase anchoring proteins (AKAPs) regulate cyclic
AMP-dependent protein kinase (PKA) signaling in
space and time. Dual-specific AKAP 2 (D-AKAP2)
binds to the dimerization/docking (D/D) domain of
both RI and RII regulatory subunits of PKA with high
affinity. Here we have determined the structures of
the RIa D/D domain alone and in complex with
D-AKAP2. The D/D domain presents an extensive
surface for binding through a well-formed N-terminal
helix, and this surface restricts the diversity of AKAPs
that can interact. The structures also underscore the
importance of a redox-sensitive disulfide in affecting
AKAP binding. An unexpected shift in the helical
register of D-AKAP2 compared to the RIIa:D-AKAP2
complex structure makes the mode of binding to
RIa novel. Finally, the comparison allows us to
deduce a molecular explanation for the sequence
and spatial determinants of AKAP specificity.
INTRODUCTION
Numerous signaling pathways are regulated by phosphoryla-
tion of target proteins, a phenomenon in which cyclic AMP
(cAMP)-dependent protein kinase (PKA) plays a central role.
Correct spatiotemporal localization of signaling molecules
such as PKA is central to the intricacies of signal transduction.
A family of proteins called the A-kinase-anchoring proteins
(AKAPs) carries out this function for PKA, and characterization
of PKA:AKAP complexes is thus important for understanding
the mechanisms of regulation.
PKA is a homodimer of regulatory (R) subunits bound to two
catalytic (C) subunits and, based on the R subunit, the enzyme
is classified as type I or II (with a and b subclasses) (Skalhegg
and Tasken, 1997). Although all four R subunits share a similar
domain organization, they are not functionally redundant and
are localized differently in the cell. For example, RIa null mice
are embryonically lethal, showing that its function is crucial forStructure 18, 155normal development (Amieux et al., 1997). Mutations in the RIa
gene cause familial cardiac myxomas and Carney complex
(Casey et al., 2000; Kirschner et al., 2000). Whereas RII subunits
are localized to discrete parts of the cell, RI subunits are usually
distributed diffusely in the cell (Wong and Scott, 2004) and then
dynamically recruited to discrete sites such as the cap site of
activated lymphocytes (Levy et al., 1996; Skalhegg et al., 1994).
Each R subunit is composed of a dimerization/docking (D/D)
domain at the N terminus followed by a linker containing an inhib-
itor site and, finally, two cAMP-binding domains (Figure 1A) (re-
viewed in Taylor et al., 2005). The D/D domains form an X-type,
antiparallel four-helix bundle that serves as a docking surface for
AKAPs (Banky et al., 1998; Harris et al., 1994; Newlon et al.,
2001), which interact with the docking surface through an amphi-
pathic helix (ca. 16 residues) (Banky et al., 1998; Gold et al.,
2006; Kinderman et al., 2006; Newlon et al., 2001). Whereas
AKAPs were initially identified by their ability to bind RII subunits,
in recent years several AKAPs such as D-AKAP1 (Huang et al.,
1997b), D-AKAP2 (Huang et al., 1997a), AKAP220 (Reinton
et al., 2000), Merlin (Gronholm et al., 2003), and Pap7 (Li et al.,
2001) have been shown to bind RI subunits as well, thereby
making them dual specific.
Dual-specific AKAP 2 (D-AKAP2) is amultisubunit protein con-
taining two putative regulator of G protein signaling (RGS)-like
homology domains, followed by a 27-residue PKA-binding
(AKB) domain and finally a PSD-95/DlgA/ZO-1 (PDZ)-binding
motif at the C terminus (Figure 1B) (Huang et al., 1997a). The
AKB domain of D-AKAP2 can bind to the D/D domains of both
RI and RII with high affinity (KD = 48 and 2 nM, respectively)
(Burns et al., 2003), showing that the motif has all the information
necessary and sufficient for binding both R subunits.
The binding of the AKB region to R subunits has been charac-
terized extensively using biochemical, biophysical, and struc-
tural methods. These include mutational studies of RI and RII
to identify residues involved in dimerization and anchoring
(Banky et al., 1998; Burns et al., 2003), and hydrogen/deuterium
exchange mass spectrometry (H/D MS) of RI and RII bound to
the D-AKAP2 AKB to determine the regions that are protected
upon binding (Burns-Hamuro et al., 2005). Peptide arrays were
used to determine RI versus RII specificity and design isoform-
specific peptides to disrupt the PKA:AKAP interaction (Alto–166, February 10, 2010 ª2010 Elsevier Ltd All rights reserved 155
Figure 1. The Functional Domain Structures
of RIa and D-AKAP2
The domain structures of RIa (A) and D-AKAP2 (B)
are shown. In RI, the dimerization/docking (D/D)
domain, inhibitor sequence, and the two cAMP-
binding domains are labeled. In D-AKAP2, the
RGS-like domains, A-kinase-binding (AKB) region,
and C-terminal PDZ motif are indicated. The
sequences of the RIa D/D domain and the
D-AKAP2 AKB region used for crystallization are
shown and numbered. Residues involved in
a helices are indicated by a solid bar and every
tenth residue is indicated by a dot. In RIa D/D,
green and red stars indicate residues crucial for
dimerization and docking to AKAP, respectively.
The conserved Cys residues are highlighted in
yellow. In D-AKAP2, residues not modeled and
modeled as Ala in the structure are indicated in
black and blue, respectively.
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et al., 2006). Finally, single-nucleotide polymorphism (SNP) anal-
yses showed that a single amino acid change (Val to Ile) in the
AKB region results in reduced binding to RIa compared to RIIa
and changes in the cellular distribution of RIa (Kammerer et al.,
2003). This SNP is associated with myocardial infarction (Nishi-
hama et al., 2007; Yoshida et al., 2007), heart rate dysregulation
(Tingley et al., 2007), and familial breast cancer (Wirtenberger
et al., 2007).
The initial steps toward establishing a D/D domain:AKAP inter-
action were the NMR structure determinations of RIIa D/D (New-
lon et al., 2001) and RIa D/D (Banky et al., 2003). The two struc-
tures have a similar four-helix bundle organization, but unique to
the RIaD/D domain is an N-terminal helix (named a0 or N-1 helix)
that is stabilized by an intersubunit disulfide bond (Figure 1A).
Although this helix is well formed, its position relative to the
four-helix core is variable due to the flexibility of the a0-a1 loop
(Banky et al., 2003). Recently, it was also shown in cardiac
myocytes that upon H2O2 treatment there is increased disul-
fide-bond formation in the RIa D/D and nuclear localization of
PKA, an effect attributed to the enhanced anchoring by AKAP
(Brennan et al., 2006). The presence of the N-terminal helix
and the disulfide bonds in the RIa isoform begs the question:
what roles do they play in anchoring AKAPs?
In order to further understand the molecular basis of AKAP
anchoring, structures of RIIa D/D with D-AKAP2 (Kinderman
et al., 2006) and with an RII-selective peptide, AKAP-IS (Gold
et al., 2006), were recently determined. Through an amphipathic
helix, the asymmetric sequences of the AKAPs bind diagonally
across the symmetric D/D domain. Interestingly, the N terminus
of one monomer is ordered and makes critical interactions with
the AKAP, whereas theN terminus of the othermonomer is disor-
dered. This flexibility was suggested to give the RII isoform the
ability to bind a wider variety of AKAP sequences.156 Structure 18, 155–166, February 10, 2010 ª2010 Elsevier Ltd All rights reservedThe RIIa D/D:D-AKAP2 structure was
used to predict isoform differences of
binding. For example, it was proposed
that the disulfide-bonded Cys residues
in RIa would be structurally equivalent toan Ile and Leu of RIIa and, therefore, would play equivalent roles
in AKAP binding. Further, explanations for strong preferences for
certain residues in D-AKAP2 for RIIa over RIa were also made
based on a predicted RIa:D-AKAP2 binding. In summary,
although these structures yielded important clues, the central
question still remained: what are the structural determinants
that render D-AKAP2 dual specific and AKAPs in general RI,
RII, or dual specific?
To answer these questions and to complete the atomic-level
picture of the dual specificity of D-AKAP2, we determined the
crystal structures of the RIa D/D alone and in complex with the
D-AKAP2 AKB. Extrapolating biochemical and biophysical
data onto the structures allowed us to gain insights into the roles
of the N-terminal helix and disulfide bonds in AKAP binding. An
unexpected and novel finding is the shift in the helical register
of D-AKAP2 when bound to RIa D/D relative to RIIa D/D.
Although this result negates predictions made about AKAP
binding to RIa, it now allows us to base all conclusions about iso-
form-specific AKAP binding on a strong structural foundation.
A detailed comparison with the RIIa D/D:D-AKAP2 complex
strongly suggests that this differential mode of binding to the
PKA R subunits is true for all AKAPs.
RESULTS AND DISCUSSION
Overall Apo RIa D/D Structure
Apo RIa D/D crystals contain a monomer in the asymmetric unit,
with the obligatory homodimer generated by a crystallographic
two-fold axis. Sulfur single-wavelength anomalous diffraction
(SAD) data were used to carry out de novo phasing of the struc-
ture (Table 1). To rationally compare the structure with existing
D/D domain structures, the other half of the dimer was generated
by a crystallographic transformation. As with other D/D domains,
the RIa D/D dimer is composed of an X-type antiparallel,
Table 1. Data Collection and Refinement Statistics
Apo RIa D/D (S-SAD) Apo RIa D/D RIa D/D:D-AKAP2 Apo RIa D/D
Data Collection and Phasing
Radiation sourcea APS; 23-ID APS; 22-BM ALS; 8.2.2 In-house
Wavelength (A˚) 1.9 1.0 1.0 1.54
Number of images 804 360 200 36
Space group P6222 P6222 P212121 P6222
Unit cell (a, b, c) (A˚) 44.0, 44.0, 92.9 44.1, 44.1, 93.0 40.5, 56.2, 57.1 44.1, 44.1, 93.2
Resolution (A˚) 100–2.40 (2.49–2.40)b 100–2.00 (2.07–2.00) 100–2.30 (2.38–2.30) 100–2.90 (3.00–2.90)
Unique reflections 2202 (135) 4047 (387) 6221 (601) 1377 (134)
Multiplicity 52.0 (10.0) 36.9 (27.6) 7.5 (7.8) 3.6 (3.6)
Completeness (%) 91.8 (59.2) 99.8 (100) 99.9 (100) 96.0 (97.8)
Rmeas (%)
c 8.7 (16.8) 8.1 (36.7) 7.2 (41.6) 6.7 (23.3)
I/s 34.6 (7.9) 32.4 (11.5) 14.5 (5.5) 17.7 (6.2)
FOM: SOLVEd 0.28
FOM: RESOLVEd 0.47
Refinement
Resolution (A˚) 100–2.00 100–2.30
Number of reflections 3929 6015
Number of amino acids 50 126
Number of solvent molecules 29 30
Number of Zn2+ ions – 5
Total number of atoms 463 1058
Average B (all atoms) (A˚2) 38.6 53.2
R/Rfree (%) 18.7/24.9 18.6/25.4
Rmsd bonds (A˚) 0.006 0.007
Rmsd angles () 0.835 0.949
f/c favored region (%)e 100 100
aAPS, Advanced Photon Source, Argonne, IL, USA; ALS, Advanced Light Source, Berkeley, CA, USA.
bNumbers in parentheses correspond to values in the highest resolution shell.
c Rmeas is the multiplicity-weighted merging R factor (Diederichs and Karplus, 1997).
d Figure of merit (FOM) both before (SOLVE) and after (RESOLVE) density modification.
e Ramachandran plot quality as defined in MolProbity (Lovell et al., 2003).
Structure
D-AKAP2 Anchoring of PKA RI Isoformfour-helix bundle with each monomer contributing two helices,
a1 and a2, to the hydrophobic dimer interface (Figure 2A) (Banky
et al., 2003;Newlonet al., 2001).a0at theN terminusalso contrib-
utes to the dimer interface through two intermolecular disulfide
bonds between Cys16 and Cys37 (Figures 2A and 2B) (Banky
et al., 2003). Tyr19 and Val20 stabilize the disulfide bond through
packing interactions, and stacking interactions with His23, in
turn, stabilize Tyr19 (Figure 2A) (see Figure S1A available online).
The intermolecular disulfides in the structure warrant a
comment. Cys16 exists in two alternate conformations, with
the major conformation being the oxidized disulfide conforma-
tion (0.7 occupancy; see Experimental Procedures) (Figure 2B).
A control data set collected at the in-house X-ray source on
the apo crystal shows an intact disulfide, thereby confirming
that disulfide-bond cleavage is an artifact of synchrotron radia-
tion (Table 1). For this reason, we will treat it as a disulfide. In
our model, therefore, onemonomer forms two head-to-tail disul-
fides with a symmetry-generated monomer.
In general, the B factors of the core and the C terminus corre-
late well with previous backbone amide H/D MS experimentsStructure 18, 155(Burns-Hamuro et al., 2005). At the N terminus, Arg14 and
Glu15 form salt bridges with Glu530 and Arg430, respectively,
via crystal-packing interactions (the ‘‘prime’’ symbol denotes
symmetry-related residues), resulting in lower than average B
factors (not shown). In solution and under oxidizing conditions,
the disulfide bondwould primarily stabilize the N-terminal region.
This interpretation of the N-terminal helix is also consistent with
the apo RIa D/D NMR structures (Figure S1) (Banky et al., 2003).
RIa D/D:D-AKAP2 Complex
Overall Structure
The RIaD/D:D-AKAP2 complex crystallizes with one RIa D/D
dimer bound to D-AKAP2 in the asymmetric unit (Table 1).
Whereas the majority of the residues of the RIa D/D have clear
electron density, 15 residues of D-AKAP2 at the N and
C termini have little or no density due to disorder and, therefore,
are not modeled (Figure 1B).
D-AKAP2 binds diagonally across (55) the face of the hydro-
phobic groove formed by the two monomers burying 710 A˚2 of
the D/D interface making extensive hydrophobic and polar–166, February 10, 2010 ª2010 Elsevier Ltd All rights reserved 157
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D-AKAP2 Anchoring of PKA RI Isoforminteractions with the dimer. In the complex, RIa D/D is oxidized
and maintains its four-helix bundle structure (Figure 2C). The
N-terminal helices of both monomers are ordered and structur-
ally similar to each other. The monomer whose N terminus inter-
acts with the N terminus of D-AKAP2 is labeled ‘‘A,’’ and the
other monomer is labeled ‘‘B.’’ Only residues from a0 and a1
play a role in stabilizing the D-AKAP2 binding. The root-mean-
square deviation (rmsd) between the two RIa D/D monomers in
the complex structure is 0.5 A˚ (49 equivalent Ca atoms), indi-
cating that small differences exist. On the other hand, the rmsds
between the dimer of the complex structure and apo structure
are1.4 A˚ (98 equivalent Ca atoms), suggesting that the organi-
zation of the two monomers undergoes rearrangements, mainly
in the a0 and a1 regions, upon binding to D-AKAP2 (Figure 2D).
For example, the side chains of Leu29 and Ile33 residues
undergo large conformational changes to accommodate AKAP
residues. Residues Gln26 and Lys30 present a different rotamer
to make hydrogen bonds with residues Glu632, Asp645, and
Gln649 of D-AKAP2, thereby stabilizing the helix.
Unlike the apo structure, the N and C termini of the RIa D/D
and D-AKAP2 are not tethered artificially by crystal-packing
interactions and are relatively more mobile, as indicated by their
higher than average B factors (Figure 2E). Because the present
structure is consistent with previous H/D MS experiments
(Burns-Hamuro et al., 2005), we can conclude that the structure
is an accurate representation of how AKAPs interact with the RIa
D/D domain.
Stabilizing Interactions
Although the same residues from each monomer are involved,
high-affinity binding to D-AKAP2 is achieved by local specific
changes in the D/D structure (Figure 3A). We describe the inter-
action interface in a systematic manner for three main reasons:
first, to provide a context for the structural determinants of
binding; second, to set the stage for comparing other D/D:
AKAP complexes with the present structure; and finally, to
provide a stable foundation for modeling other AKAPs onto the
structure.
There are four main regions or pockets at the interface,
pockets I–IV (Figure 3). The residues of the D/D domain lining
the pockets define the amino acids that can bind to the pockets
and which residues are precluded. Correspondingly, binding
specificity is achieved by the specific AKAP sequence that is
bound to the pocket. This complementarity defines the speci-
ficity of the D/D domain:AKAP interaction.Figure 2. Overview of Apo RIa D/D and RIa D/D:D-AKAP2 Structures
(A) Overall structure of Apo RIa D/D showing the antiparallel, four-helix bundle. Th
the crystallographic two-fold symmetry, colored brown. The termini and helices
Cys37 are shown as ball-and-stick models and indicated by black arrows.
(B) Stereo view of the 2Fo – Fc densitymap contoured at 1 rrms (root-mean-square
reduced disulfide bond and packing residues. The secondary structural element
(C) Overall structure of the RIa D/D domain complexed with the AKB region of D-
D-AKAP2 is shown in red. The locations of the disulfide bonds are indicated by b
(D) Stereo view of overlay of the complex RIaD/D dimer with the apo RIaD/D. The
Secondary structural elements and the termini are labeled. Black arrows indicate
(E) Correlation of crystallographic B factors with H/D-exchange protection data. T
region of D-AKAP2 are plotted against residue number. The sequence of the crys
cated below the plot. Residues notmodeled ormodeled as Ala in the structure are
AKB region showed increased protection from solvent upon binding to the D/D d
consistent with the higher B factors and weak electron density.
Structure 18, 155Pocket I, composed of Leu13A, Cys16A, Glu17A, Val34B, and
Ile33B (chains A andB of the D/D domain are denoted as a super-
script), is occupied by two hydrophobic residues, Leu634 and
Ala635, from the second turn of the AKAP helix (Figure 3C).
Two residues of pocket I, Val34B and Ile33B, are tightly packed
such that the space can accommodate only an Ala residue;
any other residue would be sterically occluded.
Pockets II and III lie along the noncrystallographic two-fold
axis, and therefore identical residues from both chains of the
D/D domains are involved in the interaction. The local conforma-
tional differences, however, provide variability in binding. Pocket
II is occupied by Ile638 and Ala639 from the third turn of the
AKAP helix, which pack against Val20A, Ile33B, and Leu29B
(Figure 3C). Pocket III is occupied by Ile642 and Val643 from
the fourth turn of the AKAP helix, which interact with Leu29A,
Ile33A, and Val20B (Figure 3C). Ile642, in particular, fits very
snugly into the hydrophobic pocket and is therefore likely to be
a unique fit to the pocket.
Pocket IV, occupied by Val646 and Met647 from the fifth turn
of the AKAP helix, has similar residues lining it as pocket I.
Unique to his pocket is the involvement of Cys37A, the Cb
atom of which packs against Val646. In contrast to pocket I,
the residues in this pocket are not as tightly packed as compared
to the other pockets and therefore would offer more flexibility in
accommodating other residues (Figure 3C). For example, in
order to accommodate Val646, Ile33A undergoes a conforma-
tional change compared to the apo structure and to Ile33B of
the other monomer.
Additional hydrophobic interactions and salt bridges increase
the stability of the interaction. Toward the N terminus, Trp636
makes hydrophobic interactions with the aliphatic chain of
Lys30B. Similarly, at the C terminus, Ala650 packs against
Cys37A and Leu13B (Figure 3D). Exposed AKAP side chains
interact with either solvent molecules or D/D domain side chains.
For example, Glu632, Asp645, andGln649 form hydrogen bonds
with Lys30B, Gln26A, and Lys30A, respectively (Figure 3D).
Significance of the Disulfide Bond in AKAP Binding
Recently, Brennan et al. reported that treatment with H2O2 re-
sulted in increased disulfide formation and nuclear localization
of PKA (Brennan et al., 2006). The disulfide bond was suggested
to play a role in the anchoring of AKAPs, which in turn promoted
the increased nuclear localization. As mentioned earlier, the D/D
dimer exists in the oxidized state in the complex and is,e D/D domain monomer is colored gold, with the other monomer, generated by
are labeled. The intermolecular disulfide bonds between residues Cys16 and
electron density of map often reported ass) shows clear density for the partially
s and the residues are labeled.
AKAP2. The monomers of the D/D domain are depicted in gold and brown and
lack arrows.
RIaD/D:D-AKAP2 structure is colored as in (C) and apo RIaD/D is colored gray.
the position of the disulfide bonds.
he average main-chain B factors of the two monomers of RIa D/D and the AKB
tallized proteins and the location of the secondary structural elements are indi-
in black and blue, respectively. In previous H/DMS experiments, the core of the
omain, consistent with lower B factors. At the termini, the lack of protection is
–166, February 10, 2010 ª2010 Elsevier Ltd All rights reserved 159
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Table 2. Effect of RIa Mutations on D-AKAP2 Binding
RIa Construct KD (nM)
a
Wild-type 48
C16A 126 (3-fold)b
C37A 745 (16-fold)
Y19A 1329 (27-fold)
H23A 198 (4-fold)
a KD = EC50 calculated from curves fit to 1:1 binding model.
b Values in parentheses denote the relative decrease in binding.
Structure
D-AKAP2 Anchoring of PKA RI Isoformtherefore, a physiologically relevant AKAP-bound form. In order
to understand the effect of the disulfide bond and other structur-
ally close residues on AKAP binding, we have generated several
mutants.
Tyr19 and His23, which lie in close proximity to the disulfide
bond, when mutated to Ala interfered with disulfide-bond forma-
tion without disrupting the dimer (Figure 2B; Figure S2). This is
similar to the effects of mutating the two Cys residues to Ala
(Banky et al., 1998). The Y19A mutant protein is predominantly
reduced and the H23A mutant exists as a mixture of reduced
and oxidized proteins, suggesting that its role in maintaining di-
sulfide-bond integrity is not as important as Tyr19 (Figure S2).
Tyrosines are often found to stabilize disulfide bonds, and our
structure shows tight packing of the disulfide bond on the
aromatic ring of Tyr19 (Petersen et al., 1999; Zauhar et al., 2000).
Using fluorescence anisotropy experiments, the Cys16 and
Cys37 mutants of RIa showed a 3-fold and a 16-fold reduction
in binding to D-AKAP2 compared to the wild-type protein,
respectively (Table 2). On the other hand, the Y19A mutant
showed a 27-fold decrease and the H23A mutant a 4-fold
decrease in affinity. The fact that the Y19A mutant has the great-
est effect on D-AKAP2 binding clearly suggests that its role in
AKAP binding is greater than just disulfide stabilization.
Disulfide-bond formation upon H2O2 treatment would
decrease the flexibility of the a0 helix relative to the core and,
more importantly, would result in the assembly of pockets I
and IV (Figure 3C). This assembly would partly be stabilized by
Tyr19 and His23. This ordering of the pockets would position
critical residues such as Leu13 and Cys16 in close proximity to
the AKAP, resulting in improved binding of AKAPs to RIa.Structure Confirms Biophysical and Biochemical
Studies
Mutational Data
Mutation of Val20 and Ile25 to Ala disrupts binding to AKAPs
(Banky et al., 1998). Val20 is part of pockets II and III and is
therefore important for D-AKAP2 binding (Figures 3A and 3B).
Interestingly, Ile25 does not directly interact with D-AKAP2. A
comparison with the apo structure reveals that in order to
accommodate D-AKAP2, Ile33 (pockets I and IV) undergoes
a conformational change that is facilitated by a shift in the posi-
tion of Ile25 (Figure 3C). Thus, an I25Amutation would disrupt the
packing of Ile33, which in turn would disrupt the integrity of
pockets I and IV.
Peptide Array Information
Peptide array analyses first highlighted the importance of the
four turns of the helix for D-AKAP2 binding to the D/D domainFigure 3. Interactions between RIa D/D and D-AKAP2
(A) Schematic figure detailing the interactions between the side chains of D-AKAP
polar interactions, respectively. Pockets I–IV are indicated by blue-colored boxe
(B) Overall structure showing the interaction. The structures are colored as in (A). T
The pockets are indicated by blue-colored boxes and numbered.
(C) Close-up views of pockets I–IV correlated with peptide array data. The colori
Hamuro et al., 2003) are shown to highlight the stringent requirements for D-AK
shown to highlight the tight packing interactions at the interface.
(D) View of additional hydrophobic and polar interactions that stabilize the RIa
involved in the hydrophobic interaction are represented as surfaces and circled. H
pocket IV residues V646 and M647 are also shown.
Structure 18, 155of RIa (Burns-Hamuro et al., 2003), and our structure fully
supports this conclusion. In general, there is decreased toler-
ance for mutations in pockets I, II, and III. Ala635, as noted
earlier, is tightly nestled in pocket I, so that any mutation would
result in disruption of binding. Indeed, this is confirmed by the
peptide array, which shows that anymutation to the Ala635 posi-
tion results in the loss of binding with RIa (Figure 3C). In pocket II,
Ala639 can be changed only to a Val or an Ile (Figure 3C). The
side chain of Trp636 packs against the AKAP helix, and the
structure suggests that in its absence more changes could be
tolerated at position 639 due to increased flexibility. The avail-
ability of structures allows us to deduce such correlated changes
and also provides us with the ability to predict specificity for
unknown AKAP peptides. Finally, the physiologically relevant
Val646 to Ile SNP would result in a local shift of residues in order
to accommodate the Cd1 atom, which would then pack against
the disulfide bond. This change to Ile would be tolerated for
binding but would likely result in a local disruption of the struc-
ture, leading to reduced affinity (Figure 3C).
In another study, Carlson and coworkers (Carlson et al., 2006)
systematically mutated residues of a consensus sequence and
tested it for RIaD/D binding. Three residues found to significantly
increase binding to RIa compared to RIIa were Glu, Asp, and Ile,
corresponding to positions occupied by Trp636, Ser644, and
Val646, respectively, in D-AKAP2. Whereas Ile would make
a hydrophobic interaction, the other two residues would be
involved in stabilizing the helix through salt bridges or hydrogen-
bonding interactions with D/D domain residues. These data high-
light the observation that the helix-stabilizing interactions, as well
as the core hydrophobic interactions in pockets, are important for
high-affinity binding of AKAPs to the RIa D/D domains.
Shift in the Helical Register Presents a Novel Interface
for Binding
To deduce the isoform-specific differences of AKAP anchoring,
in this study we compared the RIa D/D complex structure with2 and RIa D/D monomers. Solid and dashed arrows indicate hydrophobic and
s and numbered.
he side chains of D-AKAP2 are also shown to indicate the interface of binding.
ng scheme is similar to (A). Previous peptide array data (modified from Burns-
AP2 binding to RIa D/D. The surfaces of residues involved in each pocket are
D/D:D-AKAP2 interaction. The coloring scheme is similar to (A). The residues
ydrogen bonds between residues are indicated by dashed lines. For orientation,
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Structure
D-AKAP2 Anchoring of PKA RI Isoformthe RIIa D/D structure in complex with a similar D-AKAP2
peptide.
An unexpected and significant difference between the two
complex structures is the shift in the a-helical register by
a complete turn! With the RIa D/D:D-AKAP2 structure as a refer-
ence, a structural alignment of RIa D/D and RIIa D/D shows that
the D-AKAP2 peptide bound to the RIIa structure is shifted
toward the N terminus by a single helical turn (Figure 4A).
Thus, pocket I of RIa D/D is occupied by D-AKAP2 residues
Leu634 and Ala635, whereas the structurally equivalent pocket
of the RIIa D/D is filled by Ile637 and Ala639 (from the next
a-helical turn). Similarly, pocket II is occupied by Ile638 and
Ala639 in RIa D/D and by Ile642 and Val643 in RIIa D/D. Based
on a structure-based sequence alignment, pockets I and II are
occupied in both RI and RII but pockets III and IV are unique in
RIaD/D (Figures 4A). Both the RIa and RIIaD/D domains present
a hydrophobic interface for AKAP interaction, so the determina-
tion of only one of the two structures would not have been suffi-
cient to predict this shift of the helix. The implications of the
helical shift for AKAP specificity are discussed in the following
section.
Overall, the cores of the D/D domains align very well with each
other and their similarity extends to the angle of binding to the
AKAP (Figure 4B). The AKAP interaction interface is less exten-
sive with RIIa D/D than with RIa D/D. In RIIa D/D, the binding
of the asymmetric D-AKAP2 sequence induces a pronounced
asymmetry in the monomers; the N terminus of only one mono-
mer becomes ordered and makes hydrophobic interactions with
the AKAP (Figure 4B). This flexibility gives it the ability to bind
tightly to a wider variety of AKAP sequences. On the other
hand, both of the N termini of RIa D/D are ordered by virtue of
the interchain disulfide bonds. Thus, the asymmetric D-AKAP2
sequence induces subtle changes in the monomers. This inflex-
ibility decreases the potential of RIa to bind to asmany AKAPs as
RIIa. The ordering of the N termini results in additional contacts
with D-AKAP2, which in turn results in a longer, ordered helix
(two additional turns of the helix compared to the RIIa:D-
AKAP2 structure).
In the case of RIIa D/D, Ile3 and Ile5 are part of the ordered N
terminus making critical hydrophobic interactions with Leu634
and Ala635 of D-AKAP2 in pocket I of RIIa D/D (nomenclature
as defined in this study). The other monomer contributesFigure 4. Comparison of RIa D/D:D-AKAP2 and RIIa D/D:D-AKAP2 Str
(A) Structural overlay of D-AKAP2 bound to RIaD/D (in red) and to RIIaD/D (in teal;
in the helical register. Pocket residues are labeled. Residues Trp636 and Asp65
D-AKAP2 bound to RIa (left) and RIIa (right) are also shown, to indicate the pock
(B) Structural overlay of the RIaD/D:D-AKAP2 complex with the RIIa D/D:D-AKAP
RIIa is colored light blue and the D-AKAP2 peptide is colored teal. The helices
houses the disulfide bond in RIa is boxed.
(C) A close-up view of the N-terminal region showing the disulfide-bond region o
peptides bound to the two structures are not shown. Cys37 is structurally equiva
counterparts.
(D) Structure-based alignment of the D-AKAP2 sequence bound to RIa and RIIa.
tenth residue is indicated by a black dot. Due to the shift in the helical register, dif
pockets are boxed and labeled. Residues that can replace the pocket residues wit
alignment in order of preference.
(E–G) Alignment of dual-specific (E), RI-specific (F), and RII-specific (G) AKAPs to t
both RIa and RIIa. Dual-specific AKAPs satisfy the requirements for binding to bot
or RII subunits.
Structure 18, 155Leu21 for the stabilization of the AKAP peptide. It was suggested
that Ile3 and Leu21 play structurally equivalent roles to Cys16
and Cys37 in the RIa D/D structure (Gold et al., 2006; Kinderman
et al., 2006). From the present structure, it is evident that
Cys37 is structurally similar to Leu21, as predicted. However,
Cys16 is not spatially aligned with Ile3. The only residue that is
spatially close to Ile3 is Leu13 from RIa D/D, although it does
not make equivalent interactions with the AKAP (Figure 4C).
Thus, the present structure allows us to validate previous predic-
tions made about the roles of RIa D/D residues in D-AKAP2
binding.
Basis for RI and RII Specificity
The specific and tight binding of AKAPs to the D/D domains is
determined by the AKAP sequence and the spatial restrictions
placed by the residues lining the pockets. Below, we describe
the specific requirements for binding to R subunits and then
propose a general model for AKAP binding to R subunits.
Requirements for RI and RII Binding
In pocket I of RIa D/D, any hydrophobic residue can replace
position Leu634 of D-AKAP2, whereas Ala635 is a unique fit. In
pocket II, residues Ile638 and Ala639 fit snugly in the space.
Based on the structure, similar residues such as Leu or Val could
replace Ile638. Peptide array analyses suggest that larger hydro-
phobic residues can also occupy this position. Either Val or Ile
can replace Ala639, but the longer Leu side chain disrupts the
pocket. The restricted space at position Ile642 in pocket III
allows it to be replaced only by Val or a smaller amino acid
such as an Ala. On the other hand, any hydrophobic residue
can replace Val643. In pocket IV, only shorter-chain hydrophobic
residues (Ile, Ala, and Leu) can occupy the Val646 position and
nearly any residue can occupy the Met647 position (Figure 4D).
Based on the structure of the RIIa D/D:D-AKAP2 complex and
peptide array analyses, spatial requirements of pockets I and II in
RIIa are very stringent. In pocket I, the Ile638 position weakly
tolerates Leu, Phe, or Val and the Ala639 position can tolerate
a change to only Ile or Val. In pocket II, Ile642 and Val643 can
tolerate a change to Val and Ile, respectively, or to Ala (Figure 4D).
Consistency of Dual-, RI-, and RII-Specific AKAP Binding
to R Subunits
With the structure-based alignment of the D-AKAP2 sequence
bound to RI and RII subunits and the AKAP sequenceuctures Revealing D-AKAP2 Specificity
Protein Data Bank ID code 2HWN) (Kinderman et al., 2006) highlighting the shift
0 at the termini are also shown, to facilitate visualization of the register shift.
et positions. Pocket residues are represented as surfaces.
2 complex. The RIaD/D complex is colored as in Figure 3A. The D/D domain of
and termini are labeled with the respective colors. The N-terminal region that
f RIa D/D and the equivalent residues from RIIa D/D. For clarity, the D-AKAP2
lent to Leu21 of RIIa, whereas Cys16 does not have any structurally equivalent
The residue numbers of the N and C termini of D-AKAP2 are shown and every
ferent residues occupy structurally equivalent pockets of RIa and RIIa. Binding
hout disrupting the interaction are shown above (for RIa) and below (for RIIa) the
he aligned D-AKAP2 sequences according to their expectedmode of binding to
h R subunits, whereas RI- or RII-specific AKAPs satisfy criteria for binding to RI
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D-AKAP2 Anchoring of PKA RI Isoformrequirements based on the properties of the pockets now estab-
lished, the likelihood of a putative AKAP being RI, RII, or dual
specific can nowbe predicted. Indeed, thismodel correctly iden-
tifies the specificity of previously established AKAPs. Further, it
confirms that the differential binding of D-AKAP2 to RI and RII
subunits is universal to all AKAPs.
An alignment of the AKB regions of two dual-specific AKAPs,
D-AKAP1 (Huang et al., 1997b) and AKAP220 (Reinton et al.,
2000), with the D-AKAP2 sequence confirms that it matches
the requirements of binding to both R subunits. For example,
in RI binding, both AKAPs would have an Ala in position Ala635
of pocket I. In pocket II, position Ala639 would have an Ile and
Val in D-AKAP1 and AKAP220, respectively. Finally, in pocket
III, position Ile642 would be occupied by a Val and Ala in
D-AKAP1 and AKAP220, respectively, both of which would be
tolerated (Figures 4D and 4E). For RII binding, D-AKAP1 would
present two Ile residues in pocket I and Val and Ile in pocket II.
These residues would be very well tolerated in these pockets
based on the structural and peptide array analyses. Similarly,
in the case of AKAP220, Ile and Val (pocket I) and Ala and Ile
(pocket II) would fulfill the requirements of binding to the RII
subunit (Figures 4D and 4E).
RIAD, a peptide that has been shown to preferentially bind to
RI, satisfies all the requirements for binding to the four RIa
pockets (Carlson et al., 2006). Although high-specificity binding
to RI was achieved by a variety of peptides, three critical muta-
tions made the peptide preferential for RI. Two residues mutated
to acidic residueswould contribute to the bindingwith RI through
helix-stabilizing interactions. These mutations would disrupt the
interaction with the RII subunit. For example, a mutation that
results in an Asp residue in position K640 would be expected
to make a hydrogen-bond interaction with Gln26 of RIa but
would clash with a Thr residue in RIIa. Interestingly, within the
core region of binding, RIAD satisfies the requirements of RIIa
D/D binding (Figures 4D and 4F).
AKAP-IS binds specifically to RIIa and, as expected, fulfills the
requirements of RII binding (Alto et al., 2003) (Figures 4D and
4G). However, for RI binding, this peptide would present an Ile
in position 635, a position that can tolerate only an Ala residue.
Thus, it is not the specificity for RII subunits but rather the preclu-
sion from RI binding that makes this peptide specific for RII
subunits.
Strategy for Predicting the Specificity of an AKAP
The structures of RIa D/D:D-AKAP2 and RIIa D/D:D-AKAP2 now
allow us to propose a strategy for deducing whether an AKAP is
likely to be an RI-, RII-, or dual-specific AKAP. Because
D-AKAP2 is the only AKAP whose structure is known with both
R subunits, it can be used as a foundation for comparisons
with putative AKAPs. The approach would be to first do a struc-
ture-based sequence alignment of the putative AKAP with the
D-AKAP2 sequence in a fashion similar to that used in this study
(Figure 4). Based on the sequence alignment, it can be deduced
whether the putative AKAP satisfies the requirements of RI and
RII binding.
Because determinants in the core region for RII binding are
fewer than for RI binding, consistency with the requirements
do not necessarily imply binding. Thus, the second step would
be to overlay the sequence onto the structures of RI and RII
bound to D-AKAP2. This would be crucial for deciding whether164 Structure 18, 155–166, February 10, 2010 ª2010 Elsevier Ltd Allresidues outside the core-interacting regions would disrupt or
enhance binding. As seen for the RIAD peptide, although the
core requirements are fulfilled, an acidic residue outside the
core region would be expected to disrupt RII binding. Similarly,
as shown before, minor changes in the AKAP sequence could
make it tolerant as seen in the case of Trp636 of D-AKAP2, the
absence of which would make position Ala639 more tolerant to
changes.
In summary, the structures presented here establish that
a single AKAP peptide binds in a different mode to different R
subunits. The shift in the a-helical register of D-AKAP2 also
raises interesting questions about the evolution of AKAP
sequences. Finally, as a general point, the register shift serves
as a cautionary tale for predicting the mode of binding to homol-
ogous proteins.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Bovine full-length RIa was expressed and purified as described previously
(Kim et al., 2007), and mutations were generated as described by Kunkel
et al. (1987). Bovine RIa D/D (residues 1–61) was expressed as described
earlier (Banky et al., 2000). Prior to purification, RIa D/D cells were suspended
and lysed in 20 mM Tris (pH 8.0), 100 mM NaCl buffer containing protease
inhibitors. The AKB region of human D-AKAP2 (residues 623–662) was cloned
as a GST-tagged protein in pGEX 4T-1 vector with an internal thrombin
cleavage site and expressed in a manner similar to RIa D/D.
Initial purification of His-RIa D/D was carried out using the Profinia protein
purification system (Bio-Rad). Briefly, a preprogrammed method was used
to bind the protein to an Ni-affinity column, followed by imidazole elution
and a desalting step. Trypsin was used to cleave the His tag and first 11 resi-
dues of the protein and then separated by batch binding to benzamidine Se-
pharose 6B resin (GE Healthcare). As a final step, RIa D/D was purified by
S75 gel filtration. The protein was concentrated to 30 mg/ml (3280 nm =
4270 M1 cm1) for crystallization. GST-D-AKAP2 was first bound to gluta-
thione Sepharose 4B resin (GE Healthcare) followed by cleavage of the tag.
The resulting protein was purified on an S75 column and concentrated to
20 mg/ml (3280 nm = 6970 M1 cm1).
For complex formation, equimolar quantities of RIaD/D dimer and D-AKAP2
were mixed and placed in ice for 30 min. The complex at a final concentration
of 25 mg/ml was used for crystallization.
Crystallization, Structure Determination, and Refinement
Crystals of RIa D/D and RIa D/D:D-AKAP2 complex appeared in a week at
room temperature using microbatch crystallization. Apo crystals grew from
a 1:1 drop containing 30% PEG 3350, 200 mM sodium formate, and 0.1 M
Bis-Tris propane (pH 9.0). Prior to data collection, the crystals were soaked
for 2 min in reservoir solution containing 10%glycerol and flash-frozen in liquid
nitrogen. RIa D/D:D-AKAP2 complex crystals were obtained by mixing equal
volumes of protein with 10% PEG 6000, 0.01 M ZnCl2, and 0.1 M MES (pH
5.5) and directly frozen in liquid nitrogen.
For structure determination and refinement, data sets were collected using
synchrotron and in-house sources and processed using HKL2000 (Table 1)
(Otwinowski and Minor, 1997). The apo RIa D/D structure was determined
using the weak anomalous signal arising from inherently present sulfur atoms.
The program SHELXD (Sheldrick, 2008) was used to locate the positions of the
sulfurs. Heavy-atom refinement and phasing followed by density modification
were performed using SOLVE/RESOLVE (Terwilliger and Berendzen, 1999).
Prior to model building and refinement, 10% of the data were set aside for
cross-validation. The structure was built manually using the program Coot
(Emsley and Cowtan, 2004), and water molecules were placed manually using
criteria described previously (Sarma et al., 2005). Anisotropic TLS refinement
as incorporated in PHENIX (Adams et al., 2002) followed by positional and indi-
vidual B factor refinements resulted in a final R/Rfree of 18.7/24.9%. The final
model has 50 residues, 29 waters, and 2 formate ions, with alternaterights reserved
Structure
D-AKAP2 Anchoring of PKA RI Isoformconformations for Cys16 and Glu35. Alternate conformations were refined
using various occupancies and the ones that yielded similar B factors for the
two conformations were chosen.
The RIa D/D:D-AKAP2 complex structure was solved by molecular replace-
ment using the program Phaser (McCoy et al., 2007) and the apo RIa D/D
monomer (residues 23–61) as the search model. Initial Fo – Fc maps clearly
showed the presence of the N-terminal residues and D-AKAP2. The residues
were carefully built into maps resulting from the 2.3 A˚ data. Positional and indi-
vidual B factor refinements were carried out using PHENIX (Adams et al.,
2002), with 10% of the reflections set aside for crossvalidation. With the two
monomers and the AKB molecule treated as rigid bodies for TLS refinement,
the structure was refined to a final R/Rfree of 18.6/25.4%. The final model
includes 30 waters and 5 Zn2+ ions. Occupancies for the 5 Zn2+ ions were
refined as described earlier (Sarma et al., 2005) and ranged from 0.4 to 1.0.
Alternate conformations were modeled for Asn24A and Cys16B of RIa D/D.
Lys61B of RIa D/D and D-AKAP2 residues 623–627 and 655–662 were not
modeled due to weak density (Figure 1B). Additionally, five D-AKAP2
N-terminal residues that were part of the GST tag were also disordered.
Lys22A and Lys61A of RIa D/D and Asp628, Gln631, Gln648, Gln651,
Tyr652, and Gln654 in D-AKAP2 were modeled as Ala due to weak side-chain
density (Figure 1B).
Because waters are an integral part of structures, the solvent molecules in
each structure were renumbered according to the strength of electron density,
with water 1 being the highest. All structural figures were prepared using
PyMOL (http://www.pymol.org).Fluorescence Anisotropy Binding Assays
The 27-amino acid region from the D-AKAP2 AKB (residues 623–650) was
synthesized and purified to greater than 95% purity by HPLC (Peptron). The
last residue was changed to Cys for fluorescent labeling. The protein
(0.5 mg) was incubated overnight with a 2-fold molar excess of fluorescein-
5-maleimide or tetramethylrhodamine-5-maleimide (Molecular Probes). The
labeled peptides were purified by HPLC and excess organic solvent was
evaporated on a Speed Vac (Savant). Concentrations were determined
using absorbance at 485 nm (3485 nm = 90,000 M
1 cm1) and 541 nm
(3541 nm = 91,000 M
1 cm1) for the fluorescein- and rhodamine-labeled
peptides, respectively. Binding studies with full-length and mutant proteins
were carried out as previously described (Burns et al., 2003).ACCESSION NUMBERS
Coordinates and structure factors have been deposited in the Protein Data
Bank under ID codes 3IM3 (RIa D/D) and 3IM4 (RIa D/D:D-AKAP2).SUPPLEMENTAL INFORMATION
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